Nature Communications (Aug 2020)

Chlorpromazine eliminates acute myeloid leukemia cells by perturbing subcellular localization of FLT3-ITD and KIT-D816V

  • Shinya Rai,
  • Hirokazu Tanaka,
  • Mai Suzuki,
  • J. Luis Espinoza,
  • Takahiro Kumode,
  • Akira Tanimura,
  • Takafumi Yokota,
  • Kenji Oritani,
  • Toshio Watanabe,
  • Yuzuru Kanakura,
  • Itaru Matsumura

DOI
https://doi.org/10.1038/s41467-020-17666-8
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 14

Abstract

Read online

Receptor tyrosine kinase mutations are frequent and associated with poor prognosis in acute myeloid leukemia (AML). Here the authors show that the antipsychotic drug chlorpromazine reduces AML cells viability by perturbing the intracellular localization of FLT3-ITD and KIT-D816V.